Assessment of blinding in clinical trials
- 29 January 2004
- journal article
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 25 (2), 143-156
- https://doi.org/10.1016/j.cct.2003.10.016
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Blinding in randomised trials: hiding who got whatThe Lancet, 2002
- Statistics Notes: Blinding in clinical trials and other studiesBMJ, 2000
- Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecologyBMJ, 1996
- Cholesterol Lowering in the ElderlyArchives of Internal Medicine, 1994
- Short Communications Assessment of blindness in the danish verapamil infarction trial II (DAVIT II)European Journal of Clinical Pharmacology, 1990
- Can Trials of Physical Treatments Be Blinded?American Journal of Physical Medicine & Rehabilitation, 1990
- How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzinePsychiatry Research, 1986
- How blind was the patient blind in AMIS?Clinical Pharmacology & Therapeutics, 1982
- AN EVALUATION OF THE DOUBLE‐BLIND DESIGN IN A STUDY COMPARING LITHIUM CARBONATE WITH PLACEBOActa Psychiatrica Scandinavica, 1976
- Ascorbic Acid for the Common ColdJAMA, 1975